JAMA: The effect of real-time continuous blood glucose monitoring on the prognosis of patients with insulin-dependent diabetes

Traditional self-monitoring of blood glucose for diabetic patients is usually fingertip blood glucose at a certain point, which is an intermittent blood glucose monitoring method
.

In recent years, continuous blood glucose monitoring (CGM) equipment has made significant progress.

Diabetes Management Hypoglycemia Recently, researchers investigated the clinical effect of real-time CGM on all types of diabetes patients.

41,753 diabetic patients receiving insulin treatment participated in the study, of which 5,673 were type I diabetic patients and 36080 were type II diabetic patients.
The patients had self-monitoring of blood glucose levels and had not used CGM before
.

Randomly receive real-time CGM or control immediately

3806 patients received real-time CGM (mean age 42.
4 years, 51% were women.

Type I diabetes accounted for 91%), and the control group included 37947 patients (mean age 63.

4 years, 49% were women, and type I diabetes accounted for 6%)

The average glycosylated hemoglobin level in the real-time CGM group decreased from 8.

In this retrospective cohort study of patients with type I diabetes and type II diabetes, real-time continuous blood glucose monitoring can help improve the level of glycated hemoglobin in patients and reduce the risk of emergency department visits and hospitalizations for hypoglycemia

In this retrospective cohort study of patients with type I diabetes and type II diabetes, real-time continuous blood glucose monitoring can help improve the level of glycated hemoglobin in patients and reduce the risk of emergency department visits and low blood sugar hospitalization.

Original source:

Andrew J.

Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
JAMA is here to leave a message